loader
Please Wait
Applying Filters...
menu
    • menu

    Finished Formulations with Hypromellose Acetate Succinate

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Hypromellose Acetate Succinate

    INACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS BY APPLICATIONS

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1CYCLOBENZAPRINE HYDROCHLORIDE

    02 1DELSTRIGO

    03 2DEXMETHYLPHENIDATE HYDROCHLORIDE

    04 1DIETHYLPROPION HYDROCHLORIDE

    05 2METHYLPHENIDATE HYDROCHLORIDE

    06 1POSACONAZOLE

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers

    01

    GRANULES
    India
    arrow
    CPhI Worldwide, Milan
    Booth #22A34
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothGranules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    METHYLPHENIDATE HYDROCHLORIDE

    Drug : METHYLPHENIDATE HYDROCHLORIDE

    Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL

    Application Number : 211796

    Country : US

    Patented : No

    Granules India

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    APOTEX

    Cyclobenzaprine Hydrochloride

    Discovery on Target
    Not Confirmed
    arrow
    APOTEX
    Canada
    arrow
    Discovery on Target
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    CYCLOBENZAPRINE HYDROCHLORIDE

    Drug : CYCLOBENZAPRINE HYDROCHLORIDE

    Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL

    Application Number : 206703

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    BIOCON PHARMA

    Posaconazole

    Discovery on Target
    Not Confirmed
    arrow
    BIOCON PHARMA
    India
    arrow
    Discovery on Target
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    POSACONAZOLE

    Drug : POSACONAZOLE

    Dosage Form : TABLET, DELAYED RELEASE; ORAL

    Application Number : 214476

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    IMPAX LABS INC

    Dexmethylphenidate Hydrochloride

    Discovery on Target
    Not Confirmed
    arrow
    IMPAX LABS INC
    U.S.A
    arrow
    Discovery on Target
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    DEXMETHYLPHENIDATE HYDROCHLORIDE

    Drug : DEXMETHYLPHENIDATE HYDROCHLORIDE

    Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL

    Application Number : 203614

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    IMPAX LABS INC

    Dexmethylphenidate Hydrochloride

    Discovery on Target
    Not Confirmed
    arrow
    IMPAX LABS INC
    U.S.A
    arrow
    Discovery on Target
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    DEXMETHYLPHENIDATE HYDROCHLORIDE

    Drug : DEXMETHYLPHENIDATE HYDROCHLORIDE

    Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL

    Application Number : 79108

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    LANNETT CO INC

    Diethylpropion Hydrochloride

    Discovery on Target
    Not Confirmed
    arrow
    LANNETT CO INC
    U.S.A
    arrow
    Discovery on Target
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    DIETHYLPROPION HYDROCHLORIDE

    Drug : DIETHYLPROPION HYDROCHLORIDE

    Dosage Form : TABLET, EXTENDED RELEASE; ORAL

    Application Number : 91680

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    LANNETT CO INC

    Methylphenidate Hydrochloride

    Discovery on Target
    Not Confirmed
    arrow
    LANNETT CO INC
    U.S.A
    arrow
    Discovery on Target
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    METHYLPHENIDATE HYDROCHLORIDE

    Drug : METHYLPHENIDATE HYDROCHLORIDE

    Dosage Form : TABLET, EXTENDED RELEASE; ORAL

    Application Number : 91695

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    MSD MERCK CO

    Doravirine; Lamivudine; Tenofovir Disoproxil Fumarate

    Discovery on Target
    Not Confirmed
    arrow